Literature DB >> 660451

Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability.

M J Pikal, A L Lukes, J E Lang, K Gaines.   

Abstract

The solution calorimetry method is based on the observation that amorphous forms are normally significantly higher in energy than are crystalline forms. The utility and validity of the calorimetric method were investigated for cephalothin sodium, cefazolin sodium, cefamandole nafate, and cefamandole sodium. Amorphous, partially crystalline, and crystalline forms were prepared and characterized by X-ray diffraction (powder), by solution calorimetry, and, for cephalothin sodium, by the thermal decomposition rate at 50 degrees. Qualitatively, there was a good correlation between calorimetric crystallinity and the (less precise) crystallinity derived from X-ray data. The energy and structure of the amorphous state depend on the history of the sample; even samples of the same crystalline polymorph, containing no amorphous phase, may differ in energy. Thus, the absolute value of the crystallinity (X-ray or calorimetric) depends on the choice of amorphous and crystalline standards. The heat of solution is a precise (+/- 1%) and unambiguous measure of the relative crystallinity; and provided amorphous and crystalline standards are appropriately chosen, the calorimetric crystallinity correlates well with chemical stability.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660451     DOI: 10.1002/jps.2600670609

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  Quantitative correlation between initial dissolution rate and heat of solution of drug.

Authors:  K Terada; H Kitano; Y Yoshihashi; E Yonemochi
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Direct observation of the enthalpy relaxation and the recovery processes of maltose-based amorphous formulation by isothermal microcalorimetry.

Authors:  Kohsaku Kawakami; Yasuo Ida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

3.  Solid-state phase transitions initiated by water vapor sorption of crystalline L-660,711, a leukotriene D4 receptor antagonist.

Authors:  E B Vadas; P Toma; G Zografi
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 4.  Amorphous pharmaceutical solids.

Authors:  Edina Vranić
Journal:  Bosn J Basic Med Sci       Date:  2004-07       Impact factor: 3.363

5.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

6.  Estimating the critical molecular mobility temperature (T(K)) of amorphous pharmaceuticals.

Authors:  B C Hancock; K Christensen; S L Shamblin
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

7.  The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

Authors:  M J Pikal; D R Rigsbee
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

8.  A novel method for determining the solubility of small molecules in aqueous media and polymer solvent systems using solution calorimetry.

Authors:  Hala M Fadda; Xin Chen; Aktham Aburub; Dinesh Mishra; Rodolfo Pinal
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

9.  Estimation of the degree of crystallinity of cefazolin sodium by X-ray and infrared methods.

Authors:  M S Kamat; T Osawa; R J DeAngelis; Y Koyama; P P DeLuca
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

10.  Hygroscopicity of cefazolin sodium: application to evaluate the crystallinity of freeze-dried products.

Authors:  T Osawa; M S Kamat; P P DeLuca
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.